CONFALONIERI, Marco
 Distribuzione geografica
Continente #
NA - Nord America 10.710
EU - Europa 6.776
AS - Asia 2.648
SA - Sud America 89
AF - Africa 59
OC - Oceania 51
Continente sconosciuto - Info sul continente non disponibili 13
Totale 20.346
Nazione #
US - Stati Uniti d'America 10.599
IT - Italia 1.811
PL - Polonia 1.514
HK - Hong Kong 924
SE - Svezia 795
CN - Cina 794
RU - Federazione Russa 613
TR - Turchia 472
UA - Ucraina 355
DE - Germania 339
BG - Bulgaria 335
IE - Irlanda 307
GB - Regno Unito 149
FI - Finlandia 107
FR - Francia 105
IN - India 84
CH - Svizzera 78
VN - Vietnam 78
KR - Corea 68
BE - Belgio 57
CA - Canada 56
MX - Messico 50
SG - Singapore 50
AU - Australia 43
ES - Italia 43
IR - Iran 36
BR - Brasile 34
NL - Olanda 34
JP - Giappone 32
TW - Taiwan 30
SN - Senegal 29
AT - Austria 23
CL - Cile 14
GR - Grecia 14
NO - Norvegia 14
PT - Portogallo 14
RO - Romania 14
CO - Colombia 13
EU - Europa 13
PK - Pakistan 13
CZ - Repubblica Ceca 10
IL - Israele 10
PE - Perù 10
AR - Argentina 9
HR - Croazia 9
RS - Serbia 9
EG - Egitto 8
MY - Malesia 8
NZ - Nuova Zelanda 8
SA - Arabia Saudita 8
DK - Danimarca 7
ID - Indonesia 7
ZA - Sudafrica 7
EC - Ecuador 6
LT - Lituania 6
PH - Filippine 6
TH - Thailandia 6
BD - Bangladesh 4
HU - Ungheria 4
JO - Giordania 4
SI - Slovenia 4
TN - Tunisia 4
CM - Camerun 3
MD - Moldavia 3
NI - Nicaragua 3
YE - Yemen 3
AE - Emirati Arabi Uniti 2
DZ - Algeria 2
ET - Etiopia 2
KW - Kuwait 2
MA - Marocco 2
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
BZ - Belize 1
CI - Costa d'Avorio 1
GL - Groenlandia 1
KE - Kenya 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
PS - Palestinian Territory 1
UY - Uruguay 1
VE - Venezuela 1
Totale 20.346
Città #
Warsaw 1.508
Fairfield 1.433
Chandler 1.005
Hong Kong 905
Woodbridge 883
Ashburn 815
Wilmington 798
Houston 696
Seattle 638
Moscow 537
Princeton 518
Cambridge 505
Ann Arbor 482
Trieste 456
Jacksonville 423
Izmir 395
Sofia 332
Dublin 285
Wellsboro 275
Beijing 231
San Diego 106
Milan 91
Redwood City 85
Boardman 81
Redmond 78
Dong Ket 71
Dearborn 64
Helsinki 58
Columbus 57
Seoul 55
Bern 51
Rome 50
Dongguan 48
Norwalk 47
Brussels 46
Kocaeli 40
Bremen 37
Los Angeles 36
Phoenix 35
Venezia 35
Cividale del Friuli 32
Dakar 29
Naples 29
Udine 29
Jinan 28
Pune 27
Boydton 25
Grafing 25
Buffalo 24
Guangzhou 24
Lappeenranta 24
Des Moines 22
Florence 22
Paris 22
Falls Church 21
Shanghai 21
Fremont 20
Nanjing 20
Istanbul 19
Turin 19
Washington 19
Hefei 18
London 18
Arzene 16
Chicago 16
New York 16
Taipei 16
Torre Del Greco 16
Vienna 16
Bari 15
Toronto 15
Tucson 15
Bologna 13
Duino-Aurisina 13
Sydney 13
Fuzhou 12
Shenyang 12
Fagagna 11
La Spezia 11
Tappahannock 11
Zhengzhou 11
Brooklyn 10
Central 10
Council Bluffs 10
Hebei 10
Kunming 10
Tokyo 10
Treviso 10
Vancouver 10
Barcelona 9
Berlin 9
Buenos Aires 9
Centro 9
Chengdu 9
Obregon 9
Verona 9
Brescia 8
Dallas 8
Lisbon 8
Mykolayiv 8
Totale 15.251
Nome #
Metabolic exercise test data combined with cardiac and kidney indexes, the MECKI score: A multiparametric approach to heart failure prognosis. 633
Keratin14 mRNA expression in human pneumocytes during quiescence, repair and disease 372
The Time to Offer Treatments for COVID-19 346
Alpha-1 antitrypsin deficiency as a common treatable mechanism in chronic respiratory disorders and for conditions different from pulmonary emphysema? A commentary on the new European Respiratory Society statement 324
Acute respiratory distress syndrome 313
Complement Protein C1q binds to Hyaluronic Acid in the Malignant Pleural Mesothelioma Microenvironment and Promotes Tumour Growth 282
miR-200 family members reduce senescence and restore idiopathic pulmonary fibrosis type II alveolar epithelial cell transdifferentiation 261
Epithelial⁻Mesenchymal Transition in the Pathogenesis of Idiopathic Pulmonary Fibrosis 249
Practical recommendations for diagnosis and management of respiratory muscle weakness in late-onset Pompe disease 239
Pregnancy in patients with tuberculosis: A TBNET cross-sectional survey 233
Respiratory muscle training with enzyme replacement therapy improves muscle strength in late - onset Pompe disease. 233
Is early detection of late-onset Pompe disease a pneumologist’s affair? A lesson from an Italian screening study 227
Evaluation of the Interplay Between the Complement Protein C1q and Hyaluronic Acid in Promoting Cell Adhesion 221
Deep sedation versus minimal sedation during endobronchial ultrasound transbronchial needle aspiration 215
A retrospective study of endobronchial ultrasound transbronchial needle aspiration versus conventional transbronchial needle aspiration in diagnosis/staging of hilar/mediastinal lymph node in lung cancer: Which role in clinical practice? 212
Tumour infiltrating lymphocytes and PD-L1 expression as potential predictors of outcome in patients with malignant pleural mesothelioma 198
Effect of cystic fibrosis sputum rheology on lungs drug delivery by inhalation 195
Epidemiology of Tuberculosis and the Rise of XDR-TB 161
null 161
The Importance of Understanding the Stages of COVID-19 in Treatment and Trials 161
High-frequency percussive ventilation improves perioperatively clinical evolution in pulmonary resection 159
A novel approach based on low-field NMR for the detection of the pathological components of sputum in cystic fibrosis patients 159
High-throughput screening discovers antifibrotic properties of haloperidol by hindering myofibroblast activation 159
Keratin-14 expression in pneumocytes as a marker of lung regeneration/repair during diffuse alveolar damage 154
Nailfold Capillaroscopy Characteristics of Antisynthetase Syndrome and Possible Clinical Associations: Results of a Multicenter International Study 152
Aspiration Risk Factors, Microbiology, and Empiric Antibiotics for Patients Hospitalized With Community-Acquired Pneumonia 151
Corticosteroids do not cause harmful increase of viral load in severe H1N1 virus infection. 149
The prognostic role of Gender-Age-Physiology system in idiopathic pulmonary fibrosis patients treated with pirfenidone 146
Can low field nuclear magnetic resonance be used to monitor lung functionality of cystic fibrosis patients? 143
A Multicenter Study of Post-COVID-19 Interstitial Lung Syndrome 142
Heart failure prognosis over time: how the prognostic role of oxygen consumption and ventilatory efficiency during exercise has changed in the last 20 years 140
Herpes simplex virus (HSV) pneumonia in the non-ventilated immunocompromised host: Burden and predictors 137
Towards synchrotron phase-contrast lung imaging in patients - a proof-of-concept study on porcine lungs in a human-scale chest phantom. 134
An adalimumab-induced late-onset immune reconstitution inflammatory syndrome treated with adalimumab 130
Alveolar Epithelial Type II Cells 126
Prognostic value of cardiopulmonary exercise testing in Idiopathic Dilated Cardiomyopathy 123
Left ventricular thrombectomy in myocarditis: the epicardial scan & video-assisted transaortic approach 123
Acute respiratory failure in patients with severe community-acquired pneumonia: A prospective randomized evaluation of noninvasive ventilation 123
Sildenafil in pulmonary arterial hypertension. 122
Role of the complement protein C1q in the regulation of hyaluronic acid cleavage in malignant pleural mesothelioma 119
The value and scope of subspecialty biomedical journals: Perspectives from either side of the Atlantic. 117
Increased number and expertise of Italian respiratory high-dependency care units: The second national survey 110
Potential links between COVID-19-associated pulmonary aspergillosis and bronchiectasis as detected by high resolution computed tomography 110
A novel approach based on low field nuclear magnetic resonance for the detection of the pathological components of the sputum of cystic fibrosis patients 108
Documento AIPO-SIMeR sulla Fibrosi Polmonare Idiopatica 108
Functional Progression in Patients with Interstitial Lung Disease Resulted Positive to Antisynthetase Antibodies: A Multicenter, Retrospective Analysis 107
Effectiveness of a bronchial drainage technique (ELTGOL) in COPD exacerbations 106
Costs of the COPD. Differences between intensive care unit and respiratory intermediate care unit 106
Can rheology be useful in the cystic fibrosis frame 106
Anemia and health performance score evaluation as decisive factors for noninvasive mechanical ventilation decisions in AECOPD: Are there new key cornerstones? 105
Burden of chronic obstructive pulmonary disease 105
Radiological-pathological signatures of patients with COVID-19-related pneumomediastinum: is there a role for the Sonic hedgehog and Wnt5a pathways? 105
Accuracy of right atrial pressure estimation using a multi-parameter approach derived from inferior vena cava semi-automated edge-tracking echocardiography: a pilot study in patients with cardiovascular disorders 103
COMPLEMENT PROTEIN C1Q PRODUCTION IN MALIGNANT PLEURAL MESOTHELIOMA 100
Timing of onset affects arthritis presentation pattern in antisyntethase syndrome 99
Hydrocortisone infusion for severe community-acquired pneumonia: A preliminary randomized study 99
Long-term azithromycin use in patients with chronic obstructive pulmonary disease and tracheostomy 99
Influence of various therapeutic strategies on right ventricular morphology, function and hemodynamics in pulmonary arterial hypertension 95
The appropriate setting of noninvasive pressure support ventilation in stable COPD patients 95
Comorbidities, Cardiovascular Therapies, and COVID-19 Mortality: A Nationwide, Italian Observational Study (ItaliCO) 93
Sildenafil in severe pulmonary hypertension associated with chronic obstructive pulmonary disease: A randomized controlled multicenter clinical trial 92
Efficacy and safety of azithromycin 1 g once daily for 3 days in the treatment of community-acquired pneumonia: An open-label randomised comparison with amoxicillin-clavulanate 875/125 mg twice daily for 7 days 92
Prolonged hospitalisation for immigrants and high risk patients with positive smear pulmonary tuberculosis 91
C1q–Ha matrix regulates the local synthesis of hyaluronan in malignant pleural mesothelioma by modulating has3 expression 90
Il supporto decisionale nei processi di acquisto dei broncoscopi monouso 90
Opening of a respiratory intermediate care unit in a general hospital: Impact on mortality and other outcomes 87
Inspiratory muscle training for diaphragm dysfunction after cardiac surgery 87
Corticosteroid treatment in severe community-acquired pneumonia: Duration of treatment affects control of systemic inflammation and clinical improvement 86
To use or not to use corticosteroids for pneumonia? A clinician's perspective 86
Bosentan for patients with chronic thromboembolic pulmonary hypertension 86
Reliability of noninvasive hemodynamic assessment with Doppler echocardiography: comparison with the invasive evaluation 86
Approccio pragmatico alla diagnosi di polmonite da SARS-CoV-2 (COVID-19). Dalla fase epidemica alle fasi due e tre. 86
Italian registry of patients with alpha-1 antitrypsin deficiency: General data and quality of life evaluation 85
Corticosteroids in the treatment of severe sepsis and septic shock in adults: A systematic review 84
Low sensitivity of rapid tests detecting anti-CoV-2 IgG and IgM in health care workers’ serum for COVID-19 screening 84
Limited role for bronchoalveolar lavage to exclude Covid-19 after negative upper respiratory tract swabs: a multicenter study 83
Efficacy of pirfenidone for idiopathic pulmonary fibrosis: An Italian real life study 82
A chart of failure risk for noninvasive ventilation in patients with COPD exacerbation 82
Predictors of failure of noninvasive positive pressure ventilation in patients with acute hypoxemic respiratory failure: A multi-center study 82
Emergency Laser Treatment of a Tracheobronchial Carcinoid during ECMO 82
Noninvasive ventilation 81
Inhaled corticosteroids reduce neutrophilic bronchial inflammation in patients with chronic obstructive pulmonary disease 80
The effectiveness of a bronchial drainage technique (ELTGOL) in COPD exacerbations 80
Tuberculosis screening in outpatient healthcare workers: lessons from a high-income, low TB burden country 80
Interstitial lung disease in patients with antisynthetase syndrome: a retrospective case series study 80
The Treatment of Lung Involvement in Systemic Sclerosis 79
Use of Rheology and portable Low-Field NMR for the monitoring of lung functions in cystic fibrosis patients 79
Use of low field nuclear magnetic resonance to monitor lung inflammation and the amount of pathological components in the sputum of cystic fibrosis patients 77
Out-patient high-dose-rate endobronchial brachytherapy for palliation of lung cancer: An observational study 76
Histoplasmosis capsulati in Italy: Autochthonous or imported? 76
Children under 5 years are at risk for tuberculosis after occasional contact with highly contagious patients: outbreak from a smear-positive healthcare worker 75
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials 75
Respiratory intensive care units in Italy: A national census and prospective cohort study 75
Evolution of Programmatic Definitions Used inTuberculosis Prevention and Care 75
Severity of lung involvement on chest X-rays in SARS-coronavirus-2 infected patients as a possible tool to predict clinical progression: an observational retrospective analysis of the relationship between radiological, clinical, and laboratory data 75
The role of respiratory management of Pompe disease 74
Effect of chest physiotherapy on cystic fibrosis sputum nanostructure: an experimental and theoretical approach 74
A real-life multicentric National study on nintedanib in severe idiopathic pulmonary fibrosis 73
Glucocorticoid treatment in community-acquired pneumonia 73
A preliminary open label controlled trial with bosentan in patients affected by chronic thromboembolic pulmonary hypertension (CTEPH). 72
Totale 13.355
Categoria #
all - tutte 66.079
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.079


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.058 0 0 0 0 0 0 0 0 0 0 758 300
2019/20204.136 181 184 179 756 342 471 460 379 405 328 256 195
2020/20213.123 307 197 164 343 217 232 252 331 199 396 141 344
2021/20223.213 162 241 142 240 107 187 202 145 465 320 303 699
2022/20234.122 431 488 373 472 339 655 104 309 434 66 286 165
2023/20243.647 175 153 231 183 275 448 585 772 106 227 492 0
Totale 21.409